TWST — Twist Bioscience Corp · rev $332.8M

Twist Bioscience Corp (TWST) is a diagnostics & research company listed on NASDAQ.

Latest reported TWST revenue for 2026-06-30 was $332.8M. Net income was -$109.6M. Revenue was up 55.2% from 2026-03-31 to 2026-06-30. TWST currently screens at market cap $5.16B.

Use this TWST page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the TWST quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the TWST SEC filings page. Lician reads the product cache first so this HTML stays unique to Twist Bioscience Corp even when a live quote feed is slow.

Twist Bioscience Corp latest statements (FY2025)

Latest cached year on this hub. Full TWST income, balance, and cash tables.

  • Revenue$376.6M
  • Net Income-$77.7M
  • Total Assets$641.9M
  • Total Debt$0
  • Free Cash Flow-$75.6M

TWST recent filings